Cargando…
Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting
SIMPLE SUMMARY: A subset of patients with an intermediate risk for renal cell carcinoma have an indolent disease course. For these patients, the initiation of treatment for metastatic disease can be safely delayed by entering a watchful waiting period. At present, we are not able to identify those p...
Autores principales: | Bos, Manouk K., Verhoeff, Sarah R., Oosting, Sjoukje F., Menke-van der Houven van Oordt, Willemien C., Boers, Ruben G., Boers, Joachim B., Gribnau, Joost, Martens, John W. M., Sleijfer, Stefan, van Herpen, Carla M. L., Wilting, Saskia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000042/ https://www.ncbi.nlm.nih.gov/pubmed/36900167 http://dx.doi.org/10.3390/cancers15051374 |
Ejemplares similares
-
Genome-wide DNA methylation profiling using the methylation-dependent restriction enzyme LpnPI
por: Boers, Ruben, et al.
Publicado: (2018) -
High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
por: Deger, Teoman, et al.
Publicado: (2021) -
Structure-guided sequence specificity engineering of the modification-dependent restriction endonuclease LpnPI
por: Sasnauskas, Giedrius, et al.
Publicado: (2015) -
[(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
por: Verhoeff, Sarah R., et al.
Publicado: (2023) -
Successful Trastuzumab-Deruxtecan Rechallenge After Interstitial Lung Disease: A Case Report
por: de Weger, Vincent A., et al.
Publicado: (2023)